Pelikan Technologies

Pelikan Technologies was a medical device company focused on the development of innovative blood glucose monitoring solutions for individuals with diabetes. The company is best known for its proprietary electronic lancing technology, which utilized a high-speed, electronically controlled actuator to provide a virtually painless and highly consistent blood sampling experience. Its lead product, the Pelikan Sun, was designed to improve the quality of life for diabetic patients by reducing the discomfort associated with frequent testing. The technology allowed for precise control over the depth and speed of the lancet, minimizing tissue damage. In 2008, the company was acquired by Sanofi-Aventis to integrate its advanced lancing systems into Sanofi's broader diabetes management platform. This acquisition allowed Sanofi to strengthen its position in the competitive diabetes care market by offering integrated monitoring and insulin delivery solutions.